[1]蒋云姣.隔盐灸治疗化疗相关腹泻疗效观察[J].中国中医药信息杂志,2012,19(8):66-67.[doi:10.3969/j.issn.1005-5304.2012.08.025]
 [J].zhongguo zhongyiyao xinxi zazhi,2012,19(8):66-67.[doi:10.3969/j.issn.1005-5304.2012.08.025]
点击复制

隔盐灸治疗化疗相关腹泻疗效观察

参考文献/References:

[1] National Comprehensive Cancer Network.结肠癌临床实践指南(中国版)[M/OL].[2007-10-07].http://www.nccn.org.

[2] 孙传兴.临床疾病诊断依据治愈好转标准[M].2版.北京:人民军医出版社,2002:262-263.

[3] Sabharwal A, Kerr D. Chemotherapy for colorectalcancer in the metastatic and adjuvant setting:past,present and future[J]. Expert Rev Anticancer,2007,7:477-487.

[4] 毕清,田青,赵明利,等.伊立替康治疗晚期结直肠癌所致迟发性腹泻发生规律及其临床处理[J].肿瘤研究与临床,2009,21(2):182-189.

[5] Tsavaris N, Kosmas C, Skopelitis H, et al. Sequential administration of 5-fluorouracil (5FU)/leucovorin(LV) followed by irinotecan(CPT.11) at relap seversus CPT-11 followed by 5-FU/LV in advanced colorectal carcinoma. A phase Ⅲ randomized study[J]. Chemotherapy,2007,53:282-291.

[6] Takasuna K, Hagiwara T, Watanabe K, et al. Optimal antidiarrhea treatment for antitumor agentirinotecan hydrochloride (CPT.11)- induced delayed diarrhea[J]. Cancer Chemother Pharmacol,2006, 58:494-503.

更新日期/Last Update: